---
title: PI Health Sciences vs SEQENS
slug_a: pihealthsciences
slug_b: seqens
site: cdmo
review_signal_gate: closed
canonical_path: /compare/pihealthsciences/seqens
generated_by: BioBM Editorial AI
---

# PI Health Sciences vs SEQENS

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

PI Health Sciences (pihealthsciences) is listed for both. Integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with AI-driven capabilities, process optimization, analytical expertise, and GMP/non-GMP scale-up across small molecules and complex chemistry.

Services: 17. Modalities: 1. Indications: 0. Locations: 5. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (17).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

SEQENS (seqens) is listed for cdmo. Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 15. Certifications: 9. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (15).

Review summary: Review summary withheld until site-level review gate opens.